263 related articles for article (PubMed ID: 22072770)
21. trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.
Hughes DJ; Dickerson CA; Shaner MS; Sample CE; Sample JT
J Virol; 2011 Nov; 85(21):11435-47. PubMed ID: 21865378
[TBL] [Abstract][Full Text] [Related]
22. A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.
Majerciak V; Yang W; Zheng J; Zhu J; Zheng ZM
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355690
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial.
Robertson KD; Hayward SD; Ling PD; Samid D; Ambinder RF
Mol Cell Biol; 1995 Nov; 15(11):6150-9. PubMed ID: 7565767
[TBL] [Abstract][Full Text] [Related]
24. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
[TBL] [Abstract][Full Text] [Related]
25. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
26. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
[TBL] [Abstract][Full Text] [Related]
27. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.
Ellis AL; Wang Z; Yu X; Mertz JE
J Virol; 2010 Jun; 84(12):6139-52. PubMed ID: 20375168
[TBL] [Abstract][Full Text] [Related]
28. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
Yoshioka M; Crum MM; Sample JT
J Virol; 2008 Feb; 82(4):1679-87. PubMed ID: 18077719
[TBL] [Abstract][Full Text] [Related]
29. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
Zhang L; Pagano JS
J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
[TBL] [Abstract][Full Text] [Related]
30. The CCCTC Binding Factor, CTRL2, Modulates Heterochromatin Deposition and the Establishment of Herpes Simplex Virus 1 Latency
Washington SD; Singh P; Johns RN; Edwards TG; Mariani M; Frietze S; Bloom DC; Neumann DM
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996085
[TBL] [Abstract][Full Text] [Related]
31. Chromatin profiling of Epstein-Barr virus latency control region.
Day L; Chau CM; Nebozhyn M; Rennekamp AJ; Showe M; Lieberman PM
J Virol; 2007 Jun; 81(12):6389-401. PubMed ID: 17409162
[TBL] [Abstract][Full Text] [Related]
32. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
Woellmer A; Arteaga-Salas JM; Hammerschmidt W
PLoS Pathog; 2012 Sep; 8(9):e1002902. PubMed ID: 22969425
[TBL] [Abstract][Full Text] [Related]
33. Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.
McClellan MJ; Wood CD; Ojeniyi O; Cooper TJ; Kanhere A; Arvey A; Webb HM; Palermo RD; Harth-Hertle ML; Kempkes B; Jenner RG; West MJ
PLoS Pathog; 2013 Sep; 9(9):e1003636. PubMed ID: 24068937
[TBL] [Abstract][Full Text] [Related]
34. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
35. Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression.
Liao Y; Yan J; Beri NR; Giulino-Roth L; Cesarman E; Gewurz BE
PLoS Pathog; 2024 Apr; 20(4):e1011939. PubMed ID: 38683861
[TBL] [Abstract][Full Text] [Related]
36. Occupancy of chromatin organizers in the Epstein-Barr virus genome.
Holdorf MM; Cooper SB; Yamamoto KR; Miranda JJ
Virology; 2011 Jun; 415(1):1-5. PubMed ID: 21550623
[TBL] [Abstract][Full Text] [Related]
37. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
Schaefer BC; Paulson E; Strominger JL; Speck SH
Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
[TBL] [Abstract][Full Text] [Related]
38. The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines.
Ding W; Wang C; Narita Y; Wang H; Leong MML; Huang A; Liao Y; Liu X; Okuno Y; Kimura H; Gewurz B; Teng M; Jin S; Sato Y; Zhao B
J Virol; 2022 Sep; 96(18):e0073922. PubMed ID: 36094314
[TBL] [Abstract][Full Text] [Related]
39. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.
Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH
J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516
[TBL] [Abstract][Full Text] [Related]
40. Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.
Zhang L; Pagano JS
Mol Cell Biol; 1999 Apr; 19(4):3216-23. PubMed ID: 10082588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]